应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
JNJ 强生
休市中 11-22 16:00:00 EST
155.17
-0.33
-0.21%
盘后
155.00
-0.17
-0.11%
19:59 EST
最高
157.12
最低
154.11
成交量
826.60万
今开
155.90
昨收
155.50
日振幅
1.93%
总市值
3,736亿
流通市值
3,730亿
总股本
24.08亿
成交额
12.84亿
换手率
0.34%
流通股本
24.04亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
强生(JNJ.US)抗体疗法再向FDA递交监管申请 治疗中度至重度活动性溃疡性结肠炎
智通财经 · 16:51
强生(JNJ.US)抗体疗法再向FDA递交监管申请 治疗中度至重度活动性溃疡性结肠炎
更新版 1-更新 2-赛诺菲计划改变医院药品折扣计划
Reuters · 11-23 06:01
更新版 1-更新 2-赛诺菲计划改变医院药品折扣计划
华尔街日报》报道:赛诺菲计划改变医院药品折扣计划
路透中文 · 11-23 01:15
华尔街日报》报道:赛诺菲计划改变医院药品折扣计划
更新 2-华尔街日报》报导:赛诺菲计划改变医院药品折扣计划
Reuters · 11-23 01:15
更新 2-华尔街日报》报导:赛诺菲计划改变医院药品折扣计划
强生上涨1.25%,报155.03美元/股
金融界 · 11-22 01:28
强生上涨1.25%,报155.03美元/股
连吉利德都在裁员!跨国药企在中国疯狂“淘金”背后
E药经理人 · 11-20
连吉利德都在裁员!跨国药企在中国疯狂“淘金”背后
被曝裁员20%!强生降本能否增效?
北京商报 · 11-20
被曝裁员20%!强生降本能否增效?
媒体-随着本土竞争加剧,J&J和默克在华裁员 - 彭博新闻社
Reuters · 11-20
媒体-随着本土竞争加剧,J&J和默克在华裁员 - 彭博新闻社
健康巡讲:血液稀释剂无益于低风险心房颤动患者
路透中文 · 11-20
健康巡讲:血液稀释剂无益于低风险心房颤动患者
医疗保健行业高管预计 2025 年将有更多首次公开募股和企业交易
Reuters · 11-19
医疗保健行业高管预计 2025 年将有更多首次公开募股和企业交易
BUZZ-Labcorp 下跌;任职十年之久的首席财务官将退休
路透中文 · 11-19
BUZZ-Labcorp 下跌;任职十年之久的首席财务官将退休
跨国医疗巨头,新一轮裁员开启
21世纪经济报道 · 11-19
跨国医疗巨头,新一轮裁员开启
强生(JNJ.US)口服IL-23R拮抗剂两项III期研究获得积极关键结果
智通财经 · 11-19
强生(JNJ.US)口服IL-23R拮抗剂两项III期研究获得积极关键结果
强生口服IL-23R拮抗剂两项III期研究成功,拟申报上市
医药魔方Info · 11-19
强生口服IL-23R拮抗剂两项III期研究成功,拟申报上市
J&J公司的皮肤病药物达到后期研究的主要目标
Reuters · 11-19
J&J公司的皮肤病药物达到后期研究的主要目标
强生中国启动裁员,部分外企重估中国业务加深本土化
第一财经 · 11-18
强生中国启动裁员,部分外企重估中国业务加深本土化
强生中国启动裁员,部分外企重估中国业务加深本土化
第一财经 · 11-18
强生中国启动裁员,部分外企重估中国业务加深本土化
金十数据整理:每日美股市场要闻速递(11月18日 周一)
美港电讯 · 11-18
金十数据整理:每日美股市场要闻速递(11月18日 周一)
强生中国被曝裁员!被裁员工:外科部门裁员最多
红星资本局 · 11-18
强生中国被曝裁员!被裁员工:外科部门裁员最多
强生中国再裁员20%,持续“降本增效”
快马财媒 · 11-18
强生中国再裁员20%,持续“降本增效”
加载更多
公司概况
公司名称:
强生
所属市场:
NYSE
上市日期:
--
主营业务:
强生公司于1887年在新泽西州成立。强生公司及其子公司在全球拥有大约152,700名员工,从事医疗保健领域的广泛产品的研发,生产和销售。强生公司是一家控股公司,在全球几乎所有国家/地区都有260多家运营公司开展业务。公司的主要重点是与人类健康和福祉相关的产品。强生执行委员会是主要的管理团队,负责公司的战略运营和资源分配。委员会负责监督和协调公司三个业务部门的活动:消费者,制药和医疗设备。
发行价格:
--
{"stockData":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"强生","latestPrice":155.17,"timestamp":1732309200000,"preClose":155.5,"halted":0,"volume":8265961,"hourTrading":{"tag":"盘后","latestPrice":155,"preClose":155.17,"latestTime":"19:59 EST","volume":1676322,"amount":260114397.14537,"timestamp":1732323589238},"delay":0,"floatShares":2404052467,"shares":2407622972,"eps":6.042155,"marketStatus":"休市中","marketStatusCode":7,"change":-0.33,"latestTime":"11-22 16:00:00 EST","open":155.9,"high":157.115,"low":154.11,"amount":1283725978.73509,"amplitude":0.019325,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.042155,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":-797371200000,"adjPreClose":155.5,"adrRate":0,"dividendRate":0.03132,"preHourTrading":{"tag":"盘前","latestPrice":156.27,"preClose":155.5,"latestTime":"09:29 EST","volume":1074,"amount":167268.29346000002,"timestamp":1732285794019},"postHourTrading":{"tag":"盘后","latestPrice":155,"preClose":155.17,"latestTime":"19:59 EST","volume":1676322,"amount":260114397.14537,"timestamp":1732323589238},"volumeRatio":0.8930558766650644,"impliedVol":0.1719,"impliedVolPercentile":0.2143},"requestUrl":"/m/hq/s/JNJ","defaultTab":"news","newsList":[{"id":"2485690769","title":"强生(JNJ.US)抗体疗法再向FDA递交监管申请 治疗中度至重度活动性溃疡性结肠炎","url":"https://stock-news.laohu8.com/highlight/detail?id=2485690769","media":"智通财经","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485690769?lang=zh_cn&edition=full","pubTime":"2024-11-24 16:51","pubTimestamp":1732438261,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,强生宣布已向美国FDA提交补充生物制品许可申请,寻求批准其抗IL-23抗体Tremfya作为皮下注射诱导方案,用于治疗中度至重度活动性溃疡性结肠炎的成人患者。据悉,Tremfya是一款全人源单克隆抗体。除了靶向IL-23,该抗体也可同时与生产IL-23细胞上的受体CD64相结合。IL-23是由活化的单核细胞/巨噬细胞和树突状细胞分泌的细胞因子,是UC等免疫介导疾病的驱动因素。这一批准基于3期QUASAR研究的数据,该研究验证了Tremfya在UC患者中的疗效和安全性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2468319806.SGD","LU1674673428.USD","LU0466842654.USD","LU1066051225.USD","LU0320765646.SGD","LU0058720904.USD","LU1059921491.USD","JNJ","IE00B19Z3581.USD","LU0289739699.SGD","BK4568","LU1506573853.SGD","LU1914381329.SGD","LU1221951129.SGD","IE00BJT1NW94.SGD","LU0203347892.USD","LU1244550494.USD","IE00BVYPNV92.GBP","LU1244550221.USD","LU1280957306.USD","LU1732799900.SGD","LU0122379950.USD","LU1929549753.HKD","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU0345770993.USD","LU0345769128.USD","LU0882574055.USD","LU1066051498.USD","LU0345769631.USD","LU1674673691.USD","IE00B42XCP33.USD","IE0002141913.USD","LU2089984988.USD","LU0114720955.EUR","BK4585","LU0203345920.USD","BK4592","IE00B4R5TH58.HKD","LU1032466523.USD","IE00BVYPNW00.USD","LU1221951046.USD","IE00B1BXHZ80.USD","LU1066051811.HKD","IE000M9KFDE8.USD","SG9999002232.USD","LU0889566641.SGD","LU0640476718.USD","BK4550","LU0234572021.USD"],"gpt_icon":0},{"id":"2485217280","title":"更新版 1-更新 2-赛诺菲计划改变医院药品折扣计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2485217280","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485217280?lang=zh_cn&edition=full","pubTime":"2024-11-23 06:01","pubTimestamp":1732312871,"startTime":"0","endTime":"0","summary":"赛诺菲的新计划将要求医疗机构在根据一项名为340B的计划获得联邦政府规定的折扣之前,提供药房和医疗报销信息,如药品订单或病人的医院就诊信息。根据赛诺菲的新计划,340B 计划覆盖的某些医院将以全价从批发商处订购药品。礼来公司起诉卫生资源与服务管理局,指控该局阻止该公司改变向医院提供药品折扣方式的计划。礼来公司表示,其计划旨在每周直接向 340B 涵盖实体支付现金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU1221951046.USD","LU1868836914.USD","LU0203202063.USD","JNJ","LU1914381329.SGD","IE00B3PB1722.GBP","LU1894683264.USD","LU2491050154.USD","LU1074936037.SGD","LU1267930813.SGD","SG9999015945.SGD","IE00B4R5TH58.HKD","LU0354030438.USD","LU0203201768.USD","LU0708995401.HKD","BK4581","IE000M9KFDE8.USD","IE00BGHQF631.EUR","LU1935042991.SGD","LU0417517546.SGD","LU1261432733.SGD","LU0079474960.USD","LU2237443895.HKD","LU1064131342.USD","LU2360106947.USD","LU1244550577.SGD","LU1778281490.HKD","BK4550","IE00BK4W5M84.HKD","IE00BJJMRZ35.SGD","LU0471298694.HKD","LU1196500208.SGD","BK4568","IE00BDGV0183.EUR","LU2237443465.HKD","LU2361045086.USD","LU0882574055.USD","LU2264538146.SGD","LU1267930730.SGD","IE00B2B36J28.USD","LLY","BK4534","IE00BJT1NW94.SGD","LU1868837300.USD","IE00BVYPNW00.USD","LU0198837287.USD","IE00B1BXHZ80.USD","SGXZ31699556.SGD","BK4585"],"gpt_icon":1},{"id":"2485829914","title":"华尔街日报》报道:赛诺菲计划改变医院药品折扣计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2485829914","media":"路透中文","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485829914?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:15","pubTimestamp":1732295707,"startTime":"0","endTime":"0","summary":"公司发言人表示,赛诺菲目前不予置评。报道称,赛诺菲的新计划将于明年初生效,并将要求医疗机构在根据一项名为340B的计划获得联邦政府规定的折扣之前,提供药房和医疗报销信息,如药品订单或病人的医院就诊信息。报道还称,根据赛诺菲的新计划,某些340B计划覆盖的医院将以全价从批发商处订购药品。礼来公司起诉卫生资源与服务管理局,指控该局阻止该公司改变向医院提供药品折扣方式的计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4S3MT1AO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","BK4592","LU1066051811.HKD","LU2133065610.SGD","LU0094547139.USD","LU2361044949.HKD","LU2237443382.USD","LU1066051498.USD","LU1674673428.USD","LU2237443465.HKD","LU1032955483.USD","LU0345770308.USD","LU1035775433.USD","LU0471298777.SGD","LU1057294990.SGD","BK4007","LU0345769128.USD","SG9999015986.USD","SG9999014880.SGD","LLY","LU0912757837.SGD","LU2461242641.AUD","IE00BJJMRZ35.SGD","LU1894683264.USD","LU2491050071.SGD","JNJ","LU1732800096.USD","SGXZ51526630.SGD","IE00B19Z3581.USD","IE00BK4W5L77.USD","LU0079474960.USD","IE00B2B36J28.USD","SG9999018865.SGD","LU0882574139.USD","LU1023059063.AUD","IE00BGHQF631.EUR","LU0122379950.USD","LU1127390331.HKD","LU0203202063.USD","IE00BJT1NW94.SGD","SG9999017495.SGD","LU1868836914.USD","LU0466842654.USD","LU1430594728.SGD","LU0943347566.SGD","LU2324357040.USD","LU2347655156.SGD","LU2237443895.HKD","LU1814569148.SGD","LU1506573853.SGD"],"gpt_icon":1},{"id":"2485729919","title":"更新 2-华尔街日报》报导:赛诺菲计划改变医院药品折扣计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2485729919","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485729919?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:15","pubTimestamp":1732295707,"startTime":"0","endTime":"0","summary":"报导援引熟悉此事的人士的话说,赛诺菲计划在周五向医院发出一封信,信中概述了其新的模式。公司发言人表示,赛诺菲目前不予置评。报导还称,根据赛诺菲的新计划,某些340B计划覆盖的医院将以全价从批发商处订购药品。礼来公司起诉卫生资源与服务管理局,指控该局阻止该公司改变向医院提供药品折扣方式的计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1032955483.USD","LU1914381329.SGD","IE00B1BXHZ80.USD","LU1032466523.USD","LU1868837136.USD","IE0004445239.USD","SG9999014914.USD","LU2264538146.SGD","LU0061475181.USD","LU0320765059.SGD","LU2265009873.SGD","IE00B3PB1722.GBP","LU2361045086.USD","LU2602419157.SGD","LU1059921491.USD","LU2360106947.USD","SG9999018857.SGD","LU1988902786.USD","LU0456855351.SGD","LU1585245621.USD","LU2491050071.SGD","SG9999001176.SGD","LU1267930813.SGD","LU1127390331.HKD","LU0006306889.USD","LU0708995401.HKD","LU1732800096.USD","LU1674673691.USD","SG9999015945.SGD","LU0098860793.USD","LU2112291526.USD","LU0256863902.USD","LU1551013425.SGD","BK4581","LU0795875086.SGD","LU1804176565.USD","LU0345770308.USD","LU0109391861.USD","LU2361044865.SGD","IE00BK4W5M84.HKD","JNJ","LU1778281490.HKD","LU1069344957.HKD","LLY","LU1506573853.SGD","LU1035775433.USD","LU2237443549.SGD","SG9999014898.SGD","SG9999002232.USD","LU0058720904.USD"],"gpt_icon":1},{"id":"2485410192","title":"强生上涨1.25%,报155.03美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485410192","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485410192?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:28","pubTimestamp":1732210110,"startTime":"0","endTime":"0","summary":"11月22日,强生(JNJ)盘中上涨1.25%,截至01:28,报155.03美元/股,成交4.33亿美元。财务数据显示,截至2024年09月29日,强生收入总额663.01亿美元,同比增长3.98%;归母净利润106.35亿美元,同比减少65.81%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/22012845553370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1023059063.AUD","BK4585","LU1244550494.USD","BK4534","IE00BVYPNW00.USD","IE00BJT1NW94.SGD","LU0882574055.USD","LU1057294990.SGD","LU2468319806.SGD","LU1261432733.SGD","IE00B7SZLL34.SGD","LU1914381329.SGD","LU1732800096.USD","LU1732799900.SGD","BK4007","LU0640476718.USD","SG9999001440.SGD","SG9999002224.SGD","LU0234572021.USD","LU0289739699.SGD","LU1066053197.SGD","LU1430594728.SGD","LU0203347892.USD","LU1267930813.SGD","IE00B1BXHZ80.USD","IE00B4R5TH58.HKD","IE00B42XCP33.USD","IE00B19Z3B42.SGD","LU1221951129.SGD","LU0795875086.SGD","LU1032466523.USD","LU1935042991.SGD","LU1718418525.SGD","BK4568","LU0889566641.SGD","IE00BGHQF631.EUR","BK4559","IE000M9KFDE8.USD","IE0034235303.USD","IE0002270589.USD","IE0009355771.USD","LU0234570918.USD","LU0792757196.USD","LU0795875169.SGD","LU1894683348.USD","BK4550","IE00B2B36J28.USD","LU1066051498.USD","LU2347655156.SGD","JNJ"],"gpt_icon":0},{"id":"2484114832","title":"连吉利德都在裁员!跨国药企在中国疯狂“淘金”背后","url":"https://stock-news.laohu8.com/highlight/detail?id=2484114832","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484114832?lang=zh_cn&edition=full","pubTime":"2024-11-20 21:17","pubTimestamp":1732108668,"startTime":"0","endTime":"0","summary":"连业界以高人效著称的吉利德都开始疯狂裁员,跨国药企的集体焦虑,是一天比一天重了?同期,辉瑞、BMS、赛诺菲等跨国药企的成本削减计 划,正在持续进行中。这两点其实从吉利德三季度财报中也能窥得。也因此,吉利德的抗肿瘤业务还在“吃老本”。而吉利德要想进入全球抗肿瘤第一梯级,仍需“修炼”。而面对这些困境,裁员与回归,贯穿在了这些跨国药企的调整动作之中。同样裁员与战略调整双至的跨国药企还有赛诺菲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120212524abd21209&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120212524abd21209&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BBT3K403.USD","LU1585245621.USD","IE00B7SZLL34.SGD","LU1023059063.AUD","LU0306807586.USD","LU0795875086.SGD","LU0795875169.SGD","LU1221951046.USD","IE00B4R5TH58.HKD","SG9999002232.USD","LU1196500208.SGD","IE00BZ1G4Q59.USD","IE00BVYPNW00.USD","JNJ","LU1066051225.USD","LU2347655156.SGD","LU0289739699.SGD","LU1718418525.SGD","LU1914381329.SGD","PFE","LU1244550577.SGD","IE0009355771.USD","LU1066051498.USD","IE00B3PB1722.GBP","LU0114720955.EUR","IE00BKVL7J92.USD","LU1244550221.USD","LU0912757837.SGD","LU1267930813.SGD","IE00B1BXHZ80.USD","LU1935042991.SGD","LU0320765646.SGD","LU2602419157.SGD","LU1221951129.SGD","BK4534","GILD","BK4532","BK4566","IE00BJT1NW94.SGD","LU1778281490.HKD","BK4585","BK4550","LU0225284248.USD","SG9999002224.SGD","LU0109394709.USD","IE000M9KFDE8.USD","LU1929549753.HKD","IE00BGHQF631.EUR","LU0456855351.SGD","LU1430594728.SGD"],"gpt_icon":1},{"id":"2484219264","title":"被曝裁员20%!强生降本能否增效?","url":"https://stock-news.laohu8.com/highlight/detail?id=2484219264","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484219264?lang=zh_cn&edition=full","pubTime":"2024-11-20 19:42","pubTimestamp":1732102927,"startTime":"0","endTime":"0","summary":"强生中国多产品线被曝裁员。据媒体报道,这次裁员涉及多个部门,规模为20%,其中外科部门裁员较多。3年以下员工获N+1赔偿,3年到6年员工获N+2赔偿,6年以上员工获N+3赔偿。这一消息引起了业界的广泛关注,针对上述裁员消息是否属实,北京商报记者尝试拨打强生中国官网披露的联系电话,不过电话未有人接听。值得一提的是,近期也有消息称强生中国对其外科事业部进行了组织架构的调整。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411203245700335.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411203245700335.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","LU0640476718.USD","IE00BVYPNW00.USD","LU1585245621.USD","LU1032466523.USD","IE00B4R5TH58.HKD","LU1066051225.USD","LU2133065610.SGD","IE00B1BXHZ80.USD","LU0289739699.SGD","LU0098860793.USD","LU0792757196.USD","LU2468319806.SGD","BK4533","LU1244550494.USD","LU1023059063.AUD","LU0345770993.USD","LU2347655156.SGD","LU1074936037.SGD","BK4504","LU1244550221.USD","LU1066053197.SGD","BK4592","LU0234572021.USD","LU1059921491.USD","LU1732800096.USD","LU1778281490.HKD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU1066051811.HKD","LU0345769128.USD","JNJ","IE00BVYPNV92.GBP","LU1430594728.SGD","LU1032955483.USD","LU0345769631.USD","LU1267930813.SGD","LU1674673691.USD","BK4534","LU0882574055.USD","LU1674673428.USD","LU1506573853.SGD","IE0009355771.USD","LU0122379950.USD","LU1914381329.SGD","IE0034235303.USD","LU1162221912.USD","BK4007","LU0345770308.USD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2484166890","title":"媒体-随着本土竞争加剧,J&J和默克在华裁员 - 彭博新闻社","url":"https://stock-news.laohu8.com/highlight/detail?id=2484166890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484166890?lang=zh_cn&edition=full","pubTime":"2024-11-20 16:28","pubTimestamp":1732091290,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 11月20日 - -- 来源链接: -- 注:路透未核实此报道,不保证其准确性","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU0640476718.USD","LU2023250843.SGD","LU0203345920.USD","LU1430594728.SGD","LU2023250504.SGD","LU0912757837.SGD","IE00BVYPNW00.USD","LU1989771016.USD","SG9999014567.USD","LU0795875086.SGD","LU1023059063.AUD","LU1244550494.USD","LU1037948541.HKD","LU1894683348.USD","MRK","BK4550","IE00B1BXHZ80.USD","JNJ","LU0889566641.SGD","LU0965508806.USD","LU0058720904.USD","BK4007","SG9999013999.USD","LU1732800096.USD","LU2089984988.USD","LU1267930813.SGD","SG9999001440.SGD","LU0320765646.SGD","BK4516","LU1917777945.USD","IE0002141913.USD","LU1934455194.USD","LU1116320737.USD","BK4592","LU1061106388.HKD","LU1261432733.SGD","BK4533","LU1037948897.HKD","SG9999015358.SGD","LU1057294990.SGD","LU2112291526.USD","SG9999015341.SGD","LU1066051811.HKD","IE00B3PB1722.GBP","LU0795875169.SGD","LU0882574055.USD","BK4504","IE000M9KFDE8.USD","LU2361045086.USD"],"gpt_icon":0},{"id":"2484331974","title":"健康巡讲:血液稀释剂无益于低风险心房颤动患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2484331974","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484331974?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:11","pubTimestamp":1732043460,"startTime":"0","endTime":"0","summary":"低风险成人阿菲搏患者不能从血液稀释剂中获益 加拿大的一项研究发现,患有常见心律失常心房颤动但没有其他中风风险因素的年轻患者不太可能从血液稀释剂中获益。利伐沙班的这些病症的年综合发病率为7%,安慰剂为6.4%。两组均未发生设备故障。患者注册时的平均年龄为 64 岁。药物剂量按月增加或添加额外药物,直到收缩压低于 120 毫米汞柱。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4S3MQ1NH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","LU2089984988.USD","LU1066051811.HKD","LU2133065610.SGD","LU1066051498.USD","LU1674673428.USD","IE00BFTCPJ56.SGD","LU1778281490.HKD","IE00BVYPNV92.GBP","LU1032955483.USD","BK4532","SG9999001440.SGD","LU0795875086.SGD","IE00B7SZLL34.SGD","BK4588","IE0002270589.USD","BK4007","LU0345769128.USD","IE00BDGV0183.EUR","IE00BVYPNW00.USD","LU0912757837.SGD","LU1221951046.USD","LU1894683264.USD","LU0234570918.USD","LU0345769631.USD","JNJ","LU0320765646.SGD","LU1261432733.SGD","IE00B19Z3581.USD","LU0345770993.USD","LU0098860793.USD","IE00B2B36J28.USD","LU1244550221.USD","BK4568","IE00BGHQF631.EUR","LU1074936037.SGD","SG9999002232.USD","LU0114720955.EUR","LU1032466523.USD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1430594728.SGD","LU1935042991.SGD","LU2602419157.SGD","LU0792757196.USD","LU0234572021.USD","LU0795875169.SGD","LU2347655156.SGD"],"gpt_icon":0},{"id":"2484947840","title":"医疗保健行业高管预计 2025 年将有更多首次公开募股和企业交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2484947840","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484947840?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:06","pubTimestamp":1732025195,"startTime":"0","endTime":"0","summary":" Emma-Victoria Farr 路透法兰克福11月19日 - 杰富瑞周二发布的年度医疗保健报告显示,医疗保健行业高管和投资者预计 2025 年首次公开募股和企业交易将有所上升,地缘政治紧张局势将取代资金挑战,成为该行业面临的最大风险。人数 64%的受访者预计 2025 年将有更多的医疗保健企业首次公开募股,这也是股权资本市场将卷土重来的一个强烈信号。受访者对医疗保健行业的信心更为明显,73% 的受访者预计 2025 年 MSCI 全球医疗保健指数也将走高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","IE00BVYPNV92.GBP","LU1201861249.SGD","IE00B19Z3B42.SGD","LU0314104364.USD","IE00B1BXHZ80.USD","LU0114720955.EUR","BK4504","BK4550","LU0203345920.USD","LU1244550221.USD","JNJ","LU1935042215.USD","LU1674673691.USD","IE00BJT1NW94.SGD","LU0345770308.USD","LU1668664300.SGD","IE0009355771.USD","LU1221951046.USD","LU2133065610.SGD","IE000M9KFDE8.USD","LU1894683264.USD","BK4135","LU1059921491.USD","IE00BVYPNW00.USD","SG9999001440.SGD","LU1935042488.USD","LU2089984988.USD","LU1674673428.USD","LU0912757837.SGD","LU1221951129.SGD","IE00BSNM7G36.USD","LU0889566641.SGD","LU1935042991.SGD","LU1732800096.USD","LU1066051225.USD","LU1244550577.SGD","LU1935043023.USD","LU0345769128.USD","BK4534","BK4559","IE0002141913.USD","KKR","LU1732799900.SGD","IE00B2B36J28.USD","LU0203347892.USD","BK4585","LU2602419157.SGD","LU1280957306.USD","IE00BGHQF631.EUR"],"gpt_icon":0},{"id":"2484194184","title":"BUZZ-Labcorp 下跌;任职十年之久的首席财务官将退休","url":"https://stock-news.laohu8.com/highlight/detail?id=2484194184","media":"路透中文","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484194184?lang=zh_cn&edition=full","pubTime":"2024-11-19 21:23","pubTimestamp":1732022620,"startTime":"0","endTime":"0","summary":"BUZZ-Labcorp 下跌;任职十年之久的首席财务官将退休11月19日 - ** 实验室服务提供商Labcorp控股公司LH.N股价盘前下跌1.7%,至234.49美元 ** 该公司表示,Julia Wang将接替Glenn Eisenberg担任首席财务官,12月2日生效,因为现任首席财务官在担任该职位十多年后将退休 ** Wang最近在生物技术公司BeiGene担任首席财务官,此前曾在Alexion制药公司和强生公司任职。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4T3MQ16B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","LU1066051225.USD","LU1244550221.USD","LU1066051811.HKD","LU1280957306.USD","LH","LU1894683348.USD","BK4532","LU1732799900.SGD","BK4592","IE000M9KFDE8.USD","BK4588","LU1162221912.USD","LU1032466523.USD","SG9999002232.USD","LU0345770308.USD","IE00B2B36J28.USD","IE00B19Z3581.USD","LU0122379950.USD","LU1914381329.SGD","LU1506573853.SGD","LU0466842654.USD","JNJ","LU0234572021.USD","LU2347655156.SGD","LU1585245621.USD","IE0002270589.USD","BK4196","IE00B42XCP33.USD","688235","LU0345769128.USD","LU1244550494.USD","LU2089984988.USD","IE00BJT1NW94.SGD","LU0006061336.USD","LU1196500208.SGD","LU0114720955.EUR","BK0239","LU1221951129.SGD","LU1244550577.SGD","IE00B3PB1722.GBP","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU0234570918.USD","IE00BGHQF631.EUR","LU0640476718.USD","LU1935042991.SGD","LU1778281490.HKD","IE0034235303.USD","LU1894683264.USD"],"gpt_icon":0},{"id":"2484919797","title":"跨国医疗巨头,新一轮裁员开启","url":"https://stock-news.laohu8.com/highlight/detail?id=2484919797","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484919797?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:31","pubTimestamp":1732012315,"startTime":"0","endTime":"0","summary":"11月19日,一位强生内部人士告诉21世纪经济报道,强生中国已经开始新一轮裁员调整,主要是外科部门。“目前外科业务受到的市场冲击比较大,其实不只是企业,医院临床端也受到了一些影响。”另一位强生前员工同样向21世纪经济报道记者指出,最近强生内部确实在裁员。“强生从去年开始就不太行了,主要因为集采,去年我也就离职了。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411193244382360.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411193244382360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4581","LU1261432733.SGD","LU1732800096.USD","LU0098860793.USD","LU1066051225.USD","LU1244550221.USD","IE00BVYPNV92.GBP","01477","LU1221951046.USD","LU1280957306.USD","IE00BVYPNW00.USD","LU1894683348.USD","LU1732799900.SGD","BK4568","IE00B19Z3B42.SGD","SG9999001440.SGD","IE000M9KFDE8.USD","LU1074936037.SGD","IE0002141913.USD","LU1162221912.USD","SG9999002232.USD","IE00B19Z3581.USD","JNJ","LU0234572021.USD","LU0320765646.SGD","LU2347655156.SGD","IE00B7SZLL34.SGD","LU0203347892.USD","IE00B42XCP33.USD","LU0345769128.USD","LU2089984988.USD","LU0795875086.SGD","LU1267930813.SGD","LU0114720955.EUR","LU2468319806.SGD","LU1221951129.SGD","BK4585","LU1032955483.USD","LU2602419157.SGD","LU1430594728.SGD","IE0009355771.USD","LU1066053197.SGD","SG9999002224.SGD","BK1574","BK4504","IE00B1BXHZ80.USD","LU1674673691.USD","LU0882574055.USD","BK1191","LU1894683264.USD"],"gpt_icon":0},{"id":"2484991742","title":"强生(JNJ.US)口服IL-23R拮抗剂两项III期研究获得积极关键结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2484991742","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484991742?lang=zh_cn&edition=full","pubTime":"2024-11-19 16:41","pubTimestamp":1732005697,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,11月18日,强生宣布口服IL-23R拮抗剂Icotrokinra治疗斑块状银屑病的III期ICONIC-LEAD研究获得了积极的关键结果。这是第一款成功完成III期研究的口服IL-23R靶向药物。Icotrokinra组和安慰剂组发生不良事件的患者比例相似,分别有49.3%和49.1%的患者在第16周出现治疗期间不良事件。此外,Icotrokinra治疗特殊部位斑块状银屑病的III期ICONIC-TOTAL研究也取得了积极的结果。强生表示,这两项研究的详细数据将在近期举行的医学会议上公布,并计划将其提交至监管机构。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1732799900.SGD","BK4585","BK4533","IE00BGHQF631.EUR","LU1196500208.SGD","LU1074936037.SGD","LU1244550221.USD","LU0203345920.USD","IE0009355771.USD","LU0345770308.USD","LU1059921491.USD","LU1066053197.SGD","LU0792757196.USD","IE00BJT1NW94.SGD","LU0203347892.USD","LU0234570918.USD","IE00BDGV0183.EUR","LU2347655156.SGD","IE0034235303.USD","LU0795875086.SGD","SG9999002224.SGD","LU0912757837.SGD","BK4559","IE00B1BXHZ80.USD","LU0114720955.EUR","LU1732800096.USD","SG9999002232.USD","LU0640476718.USD","IE00BVYPNV92.GBP","LU1280957306.USD","IE00B2B36J28.USD","BK4588","IE00B3PB1722.GBP","IE00BVYPNW00.USD","LU1261432733.SGD","LU1244550494.USD","LU1430594728.SGD","LU1674673428.USD","LU1244550577.SGD","JNJ","LU1162221912.USD","LU1778281490.HKD","LU2089984988.USD","LU1894683348.USD","III","IE00B19Z3581.USD","LU0345769631.USD","IE000M9KFDE8.USD","BK4568","IE00B42XCP33.USD"],"gpt_icon":0},{"id":"2484518123","title":"强生口服IL-23R拮抗剂两项III期研究成功,拟申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2484518123","media":"医药魔方Info","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484518123?lang=zh_cn&edition=full","pubTime":"2024-11-19 16:29","pubTimestamp":1732004950,"startTime":"0","endTime":"0","summary":"11月18日,强生宣布口服IL-23R拮抗剂Icotrokinra治疗斑块状银屑病的III期ICONIC-LEAD研究获得了积极的关键结果。这是第一款成功完成III期研究的口服IL-23R靶向药物。强生表示,这两项研究的详细数据将在近期举行的医学会议上公布,并计划将其提交至监管机构。这两项研究纳入的患者数超过1500例,旨在对比Icotrokinra、氘可来昔替尼和安慰剂治疗中度至重度斑块状银屑病的安全性和有效性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120090917a2471149&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120090917a2471149&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1032955483.USD","LU2468319806.SGD","III","IE00B3PB1722.GBP","LU0320765646.SGD","LU1066053197.SGD","LU0098860793.USD","LU1244550577.SGD","LU1059921491.USD","JNJ","IE00B19Z3581.USD","IE00B2B36J28.USD","BK4532","IE0034235303.USD","LU1261432733.SGD","LU1506573853.SGD","LU1221951129.SGD","BK4134","IE00B19Z3B42.SGD","BK4007","LU1732799900.SGD","LU0122379950.USD","LU1585245621.USD","LU1196500208.SGD","LU1929549753.HKD","IE00BFTCPJ56.SGD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU0345769128.USD","LU0882574055.USD","LU2133065610.SGD","LU1066051498.USD","LU1674673691.USD","BK4559","LU1267930813.SGD","IE0002141913.USD","LU0114720955.EUR","LU0203345920.USD","BK4592","IE00BJJMRZ35.SGD","LU1023059063.AUD","BK4534","LU1718418525.SGD","SG9999002232.USD","LU1894683348.USD","LU0889566641.SGD","LU1778281490.HKD","LU1894683264.USD","LU0640476718.USD","BK4550"],"gpt_icon":0},{"id":"2484981059","title":"J&J公司的皮肤病药物达到后期研究的主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2484981059","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484981059?lang=zh_cn&edition=full","pubTime":"2024-11-19 05:36","pubTimestamp":1731965816,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透11月18日 - 强生公司 周一表示,该公司治疗一种皮肤病的药物在一项后期试验中达到了主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"gpt_icon":0},{"id":"2484132673","title":"强生中国启动裁员,部分外企重估中国业务加深本土化","url":"https://stock-news.laohu8.com/highlight/detail?id=2484132673","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484132673?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:02","pubTimestamp":1731938537,"startTime":"0","endTime":"0","summary":"跨国医疗公司在中国的业务架构调整仍在持续。近日,强生中国包括外科在内的事业部架构发生调整,紧接着传出裁员消息。第一财经记者从强生中国相关人士处了解到,强生新一轮的裁员自上周开启,波及公司的多个业务单元。另一位强生前员工对第一财经记者表示:“陆陆续续一直在裁,只是未对外公告。”他还称,中国裁员也是强生...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OZg2LX8CguPvbK3kThPzpBK314h1pmUPMj9PNA7KDAoT4AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OZg2LX8CguPvbK3kThPzpBK314h1pmUPMj9PNA7KDAoT4AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241118A09IY700","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241118A09IY700","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU1066051225.USD","IE0009355771.USD","IE00BGHQF631.EUR","LU0234572021.USD","IE00B4R5TH58.HKD","LU1066053197.SGD","LU1066051811.HKD","LU1196500208.SGD","LU0203347892.USD","JNJ","IE00B2B36J28.USD","SG9999001440.SGD","IE00BJT1NW94.SGD","LU0882574055.USD","LU2133065610.SGD","LU1221951129.SGD","LU1066051498.USD","BK4592","BK4534","IE0002270589.USD","BK4533","LU1935042991.SGD","LU2347655156.SGD","IE00B42XCP33.USD","LU1674673691.USD","BK4550","LU1032466523.USD","LU1914381329.SGD","BK4559","LU0114720955.EUR","LU0889566641.SGD","LU1732800096.USD","LU0234570918.USD","LU0345770993.USD","LU0466842654.USD","LU2602419157.SGD","IE00BDGV0183.EUR","IE00B19Z3581.USD","LU0795875086.SGD","LU1718418525.SGD","LU0795875169.SGD","IE00BVYPNV92.GBP","LU0203345920.USD","LU1894683264.USD","IE00BFTCPJ56.SGD","LU1221951046.USD","LU1929549753.HKD","IE00B7SZLL34.SGD","IE00BVYPNW00.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"2484267390","title":"强生中国启动裁员,部分外企重估中国业务加深本土化","url":"https://stock-news.laohu8.com/highlight/detail?id=2484267390","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484267390?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:00","pubTimestamp":1731938400,"startTime":"0","endTime":"0","summary":"外企在中国持续推动本土化有两个大前提:一是对中国的投资力度进一步加大;而是创新的产品要“有利可图”。近日,强生中国包括外科在内的事业部架构发生调整,紧接着传出裁员消息。 第一财经记者从强生中国相关人士处了解到,强生新一轮的裁员自上周开启,波及公司的多个业务单元。他还称,中国裁员也是强生全球裁员的一部分。 今年7月,强生中国前高管周敏涛回归,接替宋为群出任强生医疗科技中国区总裁。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-11-18/doc-incwpceh6718383.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-18/doc-incwpceh6718383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE0002141913.USD","LU1430594728.SGD","LU0345769128.USD","IE00BVYPNV92.GBP","LU2133065610.SGD","SG9999002224.SGD","IE00BDGV0183.EUR","LU0203345920.USD","LU2347655156.SGD","LU0114720955.EUR","LU1074936037.SGD","LU1032955483.USD","BK4533","BK4585","IE00B19Z3581.USD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","BK4592","LU0203347892.USD","LU1066053197.SGD","LU1244550221.USD","BK4550","LU1162221912.USD","LU1914381329.SGD","LU2602419157.SGD","LU1023059063.AUD","LU1032466523.USD","IE00B1BXHZ80.USD","LU1506573853.SGD","IE0034235303.USD","LU1244550577.SGD","IE00B3PB1722.GBP","IE0002270589.USD","LU1718418525.SGD","LU0345769631.USD","LU1894683348.USD","IE00B42XCP33.USD","BK4534","LU2089984988.USD","LU0889566641.SGD","LU1778281490.HKD","JNJ","LU1196500208.SGD","IE000M9KFDE8.USD","LU1244550494.USD","LU1280957306.USD","SG9999002232.USD","LU1732800096.USD","LU1221951129.SGD","LU1066051225.USD"],"gpt_icon":0},{"id":"2484305620","title":"金十数据整理:每日美股市场要闻速递(11月18日 周一)","url":"https://stock-news.laohu8.com/highlight/detail?id=2484305620","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484305620?lang=zh_cn&edition=full","pubTime":"2024-11-18 21:34","pubTimestamp":1731936889,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00B1BXHZ80.USD","NVDU","BK4555","LU2264538146.SGD","NVDL","NVD","LU0320765059.SGD","MCD","SG9999001424.SGD","IE00BJJMRZ35.SGD","LU0889566641.SGD","LU1066051498.USD","SG9999018857.SGD","NVDX","LU2461242641.AUD","NVDA","BK4592","HALO","2NVD.UK","NVDS","TSLA","LU0795875169.SGD","NIU","LU0719512351.SGD","LU1221951046.USD","BA","3NVD.UK","NVD2.UK","BK4527","LU2505996681.GBP","EVO","LU2237443382.USD","NVDS.UK","EH","IE00B1XK9C88.USD","JNJ","LU1778281490.HKD","LU1852331112.SGD","LU1923623000.USD","SMCI","LU2065169927.USD","NVDD","NVD3.UK","LLY","LU2360106780.USD","NVDY","SNVD.UK","LU0957791311.USD","CAAS","IE00BJJMRX11.SGD"],"gpt_icon":0},{"id":"2484625167","title":"强生中国被曝裁员!被裁员工:外科部门裁员最多","url":"https://stock-news.laohu8.com/highlight/detail?id=2484625167","media":"红星资本局","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484625167?lang=zh_cn&edition=full","pubTime":"2024-11-18 19:45","pubTimestamp":1731930316,"startTime":"0","endTime":"0","summary":"红星资本局11月18日消息,近日,有消息传出强生中国多产品线裁员。已在强生工作8年的被裁员工今日告诉红星资本局,这次裁员涉及多个部门,其中外科部门裁员较多。3年以下员工获N+1赔偿,3年到6年员工获N+2赔偿,6年以上员工获N+3赔偿。她认为,公司组织架构变化后影响较大,同时公司受带量采购政策影响,利润下降,其中外科部门的耗材受影响最大。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411183243111345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1914381329.SGD","IE00BGHQF631.EUR","SG9999001440.SGD","IE00BDGV0183.EUR","BK4585","LU1718418525.SGD","IE00B1BXHZ80.USD","LU1261432733.SGD","LU1778281490.HKD","LU1732799900.SGD","IE00BVYPNW00.USD","LU0234572021.USD","LU1074936037.SGD","IE00B42XCP33.USD","IE00BJT1NW94.SGD","LU1935042991.SGD","LU1032466523.USD","LU1057294990.SGD","LU1894683348.USD","LU1894683264.USD","LU0122379950.USD","LU0466842654.USD","LU0345770993.USD","LU0234570918.USD","IE00BSNM7G36.USD","JNJ","LU1244550221.USD","LU1066051225.USD","LU1430594728.SGD","BK4592","LU0912757837.SGD","IE000M9KFDE8.USD","LU1267930813.SGD","IE00B7SZLL34.SGD","LU1732800096.USD","LU1066051498.USD","LU1023059063.AUD","LU1244550494.USD","SG9999002232.USD","LU0345770308.USD","LU0640476718.USD","BK4533","IE00BVYPNV92.GBP","LU1162221912.USD","LU1221951129.SGD","IE00BFTCPJ56.SGD","LU2347655156.SGD","SG9999002224.SGD","IE00B3PB1722.GBP","BK4532"],"gpt_icon":0},{"id":"2484102146","title":"强生中国再裁员20%,持续“降本增效”","url":"https://stock-news.laohu8.com/highlight/detail?id=2484102146","media":"快马财媒","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484102146?lang=zh_cn&edition=full","pubTime":"2024-11-18 16:19","pubTimestamp":1731917980,"startTime":"0","endTime":"0","summary":"国际医疗健康巨头强生,中国区传出裁员消息。 据南方都市报报道,强生中国区被裁的员工表示,此次裁员规模为20%,主要涉及外科部门。近年强生陆续都有人员优化,但这次涉及架构调整,波及面更广,“....","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/ODqeBO0wE4_CzSll8dW5rkjhfrdET652Kf3_joMlAiIh0AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/ODqeBO0wE4_CzSll8dW5rkjhfrdET652Kf3_joMlAiIh0AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241118A06AFD00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241118A06AFD00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["IE00BFTCPJ56.SGD","LU1244550577.SGD","IE0034235303.USD","LU0098860793.USD","BK4559","LU1778281490.HKD","LU0114720955.EUR","LU1935042991.SGD","LU0122379950.USD","SG9999002224.SGD","IE00B2B36J28.USD","BK4550","LU0345769631.USD","LU0882574055.USD","LU1066051225.USD","IE000M9KFDE8.USD","SG9999002232.USD","LU1894683348.USD","LU1430594728.SGD","LU1244550494.USD","LU0466842654.USD","LU1059921491.USD","BK4532","LU0640476718.USD","IE00BGHQF631.EUR","LU0345770308.USD","JNJ","IE00B1BXHZ80.USD","IE00BDGV0183.EUR","LU0234572021.USD","LU1732799900.SGD","LU1914381329.SGD","LU0795875169.SGD","LU2468319806.SGD","LU1066051811.HKD","LU0234570918.USD","LU1261432733.SGD","IE0002141913.USD","BK4533","IE00BSNM7G36.USD","BK4588","LU0345769128.USD","LU0795875086.SGD","LU1506573853.SGD","LU1674673428.USD","IE00B19Z3B42.SGD","LU0345770993.USD","BK4534","LU1894683264.USD","LU0912757837.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jnj.com","stockEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":-0.0645},{"period":"3month","weight":-0.0546},{"period":"6month","weight":0.0558},{"period":"1year","weight":0.0288},{"period":"ytd","weight":-0.01}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"强生公司于1887年在新泽西州成立。强生公司及其子公司在全球拥有大约152,700名员工,从事医疗保健领域的广泛产品的研发,生产和销售。强生公司是一家控股公司,在全球几乎所有国家/地区都有260多家运营公司开展业务。公司的主要重点是与人类健康和福祉相关的产品。强生执行委员会是主要的管理团队,负责公司的战略运营和资源分配。委员会负责监督和协调公司三个业务部门的活动:消费者,制药和医疗设备。","yearOnYearQuotes":[{"month":1,"riseRate":0.522727,"avgChangeRate":0.000425},{"month":2,"riseRate":0.5,"avgChangeRate":-0.005666},{"month":3,"riseRate":0.590909,"avgChangeRate":0.016904},{"month":4,"riseRate":0.644444,"avgChangeRate":0.034378},{"month":5,"riseRate":0.488889,"avgChangeRate":-0.026323},{"month":6,"riseRate":0.511111,"avgChangeRate":0.006092},{"month":7,"riseRate":0.6,"avgChangeRate":0.012531},{"month":8,"riseRate":0.511111,"avgChangeRate":0.003584},{"month":9,"riseRate":0.488889,"avgChangeRate":0.00256},{"month":10,"riseRate":0.688889,"avgChangeRate":0.021244},{"month":11,"riseRate":0.6,"avgChangeRate":0.015978},{"month":12,"riseRate":0.659091,"avgChangeRate":0.014337}],"exchange":"NYSE","name":"强生","nameEN":"Johnson & Johnson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"强生,JNJ,强生股票,强生股票老虎,强生股票老虎国际,强生行情,强生股票行情,强生股价,强生股市,强生股票价格,强生股票交易,强生股票购买,强生股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}